Page last updated: 2024-11-01

norfluoxetine and Disease Models, Animal

norfluoxetine has been researched along with Disease Models, Animal in 3 studies

norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" In this study the anticonvulsant actions of norfluoxetine and fluoxetine were studied and compared to those of phenytoin and clonazepam in pentylenetetrazol-induced mouse epilepsy models."3.73Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. ( Harasztosi, C; Kecskeméti, V; Nánási, PP; Pál, B; Riba, P; Rusznák, Z; Szûcs, G; Wagner, R, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, KI1
Chung, YC1
Jin, BK1
Oh, JE1
Zupan, B1
Gross, S1
Toth, M1
Kecskeméti, V1
Rusznák, Z1
Riba, P1
Pál, B1
Wagner, R1
Harasztosi, C1
Nánási, PP1
Szûcs, G1

Other Studies

3 other studies available for norfluoxetine and Disease Models, Animal

ArticleYear
Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease.
    Mediators of inflammation, 2018, Volume: 2018

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons;

2018
Paradoxical anxiogenic response of juvenile mice to fluoxetine.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:10

    Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Cell Prolif

2009
Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.
    Brain research bulletin, 2005, Sep-30, Volume: 67, Issue:1-2

    Topics: Animals; Anticonvulsants; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signa

2005